Chapter/Section Purchase

1 Study Coverage
1.1 Acute Myeloid Leukemia Treatment Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022) & (US$ Million) Introduction
1.2 Global Acute Myeloid Leukemia Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global Acute Myeloid Leukemia Treatment Market Size for the Year 2017-2028
1.2.2 Global Acute Myeloid Leukemia Treatment Market Size for the Year 2017-2028
1.3 Acute Myeloid Leukemia Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Acute Myeloid Leukemia Treatment in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Acute Myeloid Leukemia Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Acute Myeloid Leukemia Treatment Market Dynamics
1.4.1 Acute Myeloid Leukemia Treatment Industry Trends
1.4.2 Acute Myeloid Leukemia Treatment Market Drivers
1.4.3 Acute Myeloid Leukemia Treatment Market Challenges
1.4.4 Acute Myeloid Leukemia Treatment Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Acute Myeloid Leukemia Treatment by Type
2.1 Acute Myeloid Leukemia Treatment Market Segment by Type
2.1.1 DC Regimen
2.1.2 AVD Regimen
2.1.3 VCD Regimen
2.2 Global Acute Myeloid Leukemia Treatment Market Size by Type (2017, 2022 & 2028)
2.3 Global Acute Myeloid Leukemia Treatment Market Size by Type (2017-2028)
2.4 United States Acute Myeloid Leukemia Treatment Market Size by Type (2017, 2022 & 2028)
2.5 United States Acute Myeloid Leukemia Treatment Market Size by Type (2017-2028)
3 Acute Myeloid Leukemia Treatment by Application
3.1 Acute Myeloid Leukemia Treatment Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Acute Myeloid Leukemia Treatment Market Size by Application (2017, 2022 & 2028)
3.3 Global Acute Myeloid Leukemia Treatment Market Size by Application (2017-2028)
3.4 United States Acute Myeloid Leukemia Treatment Market Size by Application (2017, 2022 & 2028)
3.5 United States Acute Myeloid Leukemia Treatment Market Size by Application (2017-2028)
4 Global Acute Myeloid Leukemia Treatment Competitor Landscape by Company
4.1 Global Acute Myeloid Leukemia Treatment Market Size by Company
4.1.1 Top Global Acute Myeloid Leukemia Treatment Companies Ranked by Revenue (2021)
4.1.2 Global Acute Myeloid Leukemia Treatment Revenue by Player (2017-2022)
4.2 Global Acute Myeloid Leukemia Treatment Concentration Ratio (CR)
4.2.1 Acute Myeloid Leukemia Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Acute Myeloid Leukemia Treatment in 2021
4.2.3 Global Acute Myeloid Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Acute Myeloid Leukemia Treatment Headquarters, Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022) & (US$ Million) Type
4.3.1 Global Acute Myeloid Leukemia Treatment Headquarters and Area Served
4.3.2 Global Acute Myeloid Leukemia Treatment Companies Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Acute Myeloid Leukemia Treatment Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Acute Myeloid Leukemia Treatment Market Size by Company
4.5.1 Top Acute Myeloid Leukemia Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States Acute Myeloid Leukemia Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Acute Myeloid Leukemia Treatment Market Size by Region
5.1 Global Acute Myeloid Leukemia Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Acute Myeloid Leukemia Treatment Market Size by Region (2017-2028)
5.2.1 Global Acute Myeloid Leukemia Treatment Market Size by Region: 2017-2022
5.2.2 Global Acute Myeloid Leukemia Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Acute Myeloid Leukemia Treatment Market Size YoY Growth 2017-2028
6.1.2 North America Acute Myeloid Leukemia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Acute Myeloid Leukemia Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Acute Myeloid Leukemia Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Acute Myeloid Leukemia Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe Acute Myeloid Leukemia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Acute Myeloid Leukemia Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America Acute Myeloid Leukemia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Acute Myeloid Leukemia Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Acute Myeloid Leukemia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Ambit Biosciences Corporation
7.1.1 Ambit Biosciences Corporation Company Details
7.1.2 Ambit Biosciences Corporation Business Overview
7.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Introduction
7.1.4 Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022)
7.1.5 Ambit Biosciences Corporation Recent Development
7.2 Celgene Corporation
7.2.1 Celgene Corporation Company Details
7.2.2 Celgene Corporation Business Overview
7.2.3 Celgene Corporation Acute Myeloid Leukemia Treatment Introduction
7.2.4 Celgene Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022)
7.2.5 Celgene Corporation Recent Development
7.3 Cephalon
7.3.1 Cephalon Company Details
7.3.2 Cephalon Business Overview
7.3.3 Cephalon Acute Myeloid Leukemia Treatment Introduction
7.3.4 Cephalon Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022)
7.3.5 Cephalon Recent Development
7.4 Clavis Pharma
7.4.1 Clavis Pharma Company Details
7.4.2 Clavis Pharma Business Overview
7.4.3 Clavis Pharma Acute Myeloid Leukemia Treatment Introduction
7.4.4 Clavis Pharma Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022)
7.4.5 Clavis Pharma Recent Development
7.5 Eisai
7.5.1 Eisai Company Details
7.5.2 Eisai Business Overview
7.5.3 Eisai Acute Myeloid Leukemia Treatment Introduction
7.5.4 Eisai Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022)
7.5.5 Eisai Recent Development
7.6 Genzyme Corporation
7.6.1 Genzyme Corporation Company Details
7.6.2 Genzyme Corporation Business Overview
7.6.3 Genzyme Corporation Acute Myeloid Leukemia Treatment Introduction
7.6.4 Genzyme Corporation Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022)
7.6.5 Genzyme Corporation Recent Development
7.7 Sunesis Pharmaceuticals
7.7.1 Sunesis Pharmaceuticals Company Details
7.7.2 Sunesis Pharmaceuticals Business Overview
7.7.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Introduction
7.7.4 Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Treatment Business (2017-2022)
7.7.5 Sunesis Pharmaceuticals Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer